Shareholder Information
Stock Basis
Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 to report organizational actions, including nontaxable distributions, that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only and should not be construed as legal or tax advice. Please consult with a qualified tax advisor for questions regarding your specific tax treatment.
Sept 2022 Reverse Stock Split
IRS Form 8937 – Report of Organizational Actions Affecting Basis of Securities
Please refer to this form for information regarding the 2022 Reverse Stock Split
June 2017 Redomicile
IRS Form 8937 – Report of Organizational Actions Affecting Basis of Securities
Please refer to this form for information regarding the organizational action whereby Nabriva Therapeutics plc (“Nabriva Ireland”) completed a tender offer to exchange the American depositary shares (“ADS”) and common shares of Nabriva Therapeutics GmbH (“Nabriva GmbH”) for ordinary shares of Nabriva Ireland.
July 2018 Acquisition of Zavante Therapeutics, Inc.
Form 8937 – Report of Organizational Actions Affecting Basis of Securities
Please refer to this form for information regarding the acquisition of Zavante Therapeutics, Inc. by Nabriva Therapeutics plc.
Annual General Meeting Documents
2018
Nabriva Convocation Notice for AGM 2018
2017
Nabriva Convocation Notice for AGM 2017
Resolution Proposals for the Annual General Meeting on 30 August 2017
Nabriva Therapeutics Supervisory Board Compensation Policy
Jahresabschluss, Nabriva Therapeutics AG, Wien
Beschlussvorschläge für die OHV
2016